BeStock  
Stocks › Biotechnology › ABVX

Abivax S.A. ABVX

US equityMarket cap rank #1799Biotechnology
$73.20 −$7.45 (-9.24%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $74.95 +2.39%
Open$79.01
Prev close$80.65
Day range$62.70 – $79.74
Volume14.85M
Market cap$6.41B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership114.8%-3.21 pts vs. prior quarter
Institutions holding416+18 vs. prior quarter
Insider trades (recent)0 buys / 2 sellsNet selling
Short interest4.70% of floatDays to cover 4.6 · as of 30 Oct 2026
Short-sale volume share20.9%5-day average of daily volume

Short-sale volume as % of daily volume

4%12%20%27%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$2.53M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$2.8MSuper+$301.9KBig+$3.3MMid+$1.6MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 27.4% of shares outstanding.

Largest holders

  • TCG Crossover Management, LLC6.89%
  • The Goldman Sachs Group, Inc.5.42%
  • Artal Group S.A.5.09%
  • Helikon Investments Limited5.02%
  • Darwin Global Management Limited4.99%
  • JPMorgan Chase & Co.4.48%
  • VR Management, LLC4.14%
  • Bank of America Corporation3.64%

By investor type

  • Hedge Fund34.59%
  • VC/PE Fund29.74%
  • Mutual Fund25.85%
  • Public Company15.39%
  • Private Company4.79%
  • Sovereign Wealth Fund3.68%
  • Individual/Insider1.13%
  • Endowment Fund0.48%

Reported short interest has fallen from 6.88% to 4.70% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +1,625,980 5.4%
Darwin Global Management Limited Hedge Fund 2026/Q3 +732,770 5.0%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +1,821,079 5.6%
Helikon Investments Limited Hedge Fund 2026/Q3 +1,589,713 5.0%
Two Seas Capital LP Hedge Fund 2026/Q3 +431,999 0.8%
BlackRock Mutual Fund 2026/Q3 +449,628 2.9%
Bank of America Corporation Public Company 2026/Q3 +403,659 3.6%
Fred Alger Management, LLC Mutual Fund 2026/Q3 +408,026 2.2%
Fred Alger Management, LLC Mutual Fund 2026/Q3 +391,485 2.2%
Millennium Management LLC Hedge Fund 2026/Q3 +470,719 0.3%
Norges Bank Investment Management Sovereign Wealth Fund 2026/Q3 +2,737,352 3.7%
Helikon Investments Limited Hedge Fund 2026/Q3 +1,773,807 3.2%
RA Capital Management, L.P. VC/PE Fund 2026/Q3 +1,132,557 1.3%
Janus Henderson Group plc Mutual Fund 2026/Q3 +1,035,104 2.3%
Citadel Advisors LLC Hedge Fund 2026/Q3 +894,014 1.6%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
7 Jan 2026 Sofinnova Partners SAS Intent to Sell (Form 144) -1,000,000 $133.70 –
27 Oct 2025 Sofinnova Partners SAS Intent to Sell (Form 144) -1,200,000 $92.75 –

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 4,110,784 4.7% 4.6
15 Oct 2026 7,254,941 8.3% 6.1
30 Sep 2026 7,776,429 8.9% 5.1
15 Sep 2026 6,858,511 7.9% 6.2
31 Aug 2026 6,962,029 8.0% 8.0
14 Aug 2026 6,001,787 6.9% 7.8

Discussion

No comments yet — be the first to weigh in on ABVX.

Sign in to join the discussion.

Scroll to Top